Lisinopril
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00722 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 37 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | posterolateral myocardial infarction | KG + DL |
| 2 | posteroinferior myocardial infarction | KG + DL |
| 3 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 4 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 5 | malignant renovascular hypertension | KG + DL |
| 6 | malignant hypertensive renal disease | KG + DL |
| 7 | septal myocardial infarction | KG + DL |
| 8 | Braddock syndrome | KG + DL |
| 9 | chronic pulmonary heart disease | KG + DL |
| 10 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 11 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 12 | coronary stenosis | KG + DL |
| 13 | congenital coronary artery anomaly | KG + DL |
| 14 | obsolete susceptibility to ischemic stroke | KG + DL |
| 15 | diabetic nephropathy | KG + DL |
| 16 | intracerebral hemorrhage | KG + DL |
| 17 | brain stem infarction | KG + DL |
| 18 | ABri amyloidosis | KG + DL |
| 19 | Prinzmetal angina | KG + DL |
| 20 | congenital tricuspid malformation | KG + DL |
| 21 | cerebral artery occlusion | KG + DL |
| 22 | pyropoikilocytosis, hereditary | KG + DL |
| 23 | cerebral infarction | KG + DL |
| 24 | pyruvate kinase deficiency of red cells | KG + DL |
| 25 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 26 | stroke disorder | KG + DL |
| 27 | chronic renal failure syndrome | KG + DL |
| 28 | beta-thalassemia with other manifestations | KG + DL |
| 29 | cerebrovascular disorder | KG + DL |
| 30 | congestive heart failure | KG + DL |
| 31 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 32 | acute pulmonary heart disease | KG + DL |
| 33 | scapuloperoneal myopathy | KG + DL |
| 34 | cerebral arterial disease | KG + DL |
| 35 | MRI defined brain infarct | KG + DL |
| 36 | osteoarthritis susceptibility | KG + DL |
| 37 | chronic kidney disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.